Anuja Java, MD (she/her)

Was thrilled to receive this letter about one of my transplant pts who made a donation to the hospital in my name. As physicians, the trust & well-being of our pts matters most!! This beautiful gesture tells me I am doing it right. Feeling blessed & happy😊 @WUNephrology⁩

RT @yasar_caliskan: Honored to speak at this great session alongside our distinguished moderators, Drs. Ali Gharavi and @DrRulanParekh, and esteemed mentors and colleagues, @SundaramHariha1, @christiethomas and @anuja_java. @KristaLentine, @MonaDoshiMD and @PuneetSoodMD @ASNKidney @AST_info 🙏🥰🙏

RT @edgarvlermamd: Thanks 🙏🏽 to everyone who visited @IsabellaLerma14 #KidneyWk

RT @WashUNephrology: Don't miss @anuja_java - moderator of session on complement in glomerular diseases. #KidneyWk See more on our @WashUNephrology calendar:

RT @WashUNephrology: Visit @anuja_java's session today at #KidneyWk to hear her presentation on complement-mediated kidney diseases and transplantation. See more on our@WashUNephrology calendar:

RT @onconephsociety: 📍 Happening now at @ASNKidney KidneyWeek in Denver! Join us for the ASN OncoNephrology Program for a day of cutting-edge science, emerging cancer therapies, and practical insights. Are your ready? 🫘 @onconeph @rc_oncneph @SheronLatcha @ShrutiGkidney @PaulHannaMD @hhashmi87

RT @WashUNephrology: Don’t miss @anuja_java's presentation and panel at #KidneyWk 2026 Early Program! Explore the full @WashUNephrology calendar:

RT @WashUNephrology: Denver, here we come! Check out our 2026 ASN #KidneyWk @WashUNephrology calendar of presentations, posters, and more!

RT @onconephsociety: How much kidney function is enough for the right dose? This session by @PaulHannaMD and Thomas Nolin looks at individualising GFR assessment and multidisciplinary dose adjustment of anticancer therapies in CKD and ESKD. @rc_oncneph @onconeph @SheronLatcha @ShrutiGkidney

RT @onconephsociety: 🩸Thrombotic Microangiopathy in Patients with Cancer 🩸 Cancer associated TMA can be complex, especially when complement activation is involved. This session by @anuja_java will explore the role of complement regulation and inhibition in these patients. @rc_oncneph @onconeph

RT @onconephsociety: Our next session? 🩺Case Based Debates in Onconephrology ➡️ To Transplant or Not to Transplant in patients with cancers ? Discussants : Nadia Al Haddad, @hhashmi87 @anuja_java @nymurakami @itunuowoyemi Register 🔗: @rc_oncneph @onconeph @SheronLatcha

RT @onconephsociety: 🦀🫘👩🏻‍⚕️Kidney Transplant Onconephrology How do we approach cancer treatment in KTRs? Dr Murakami @nymurakami discusses immunotherapy, engineered cellular therapies and management of PTLDs Register 🔗 : @onconeph @SheronLatcha @rc_oncneph @ShrutiGkidney

RT @onconephsociety: ✨Session 4: AKI and Electrolyte Disturbances in Cancer and Novel Targeted Therapies Cancer therapies continue to evolve, and so do the kidney complications we see with them. 🎙️ : @ZiolkowskiSusan @onconeph @SheronLatcha @MaulinPatelDO Register :

RT @onconephsociety: Next off, we discuss Novel Radioligand Therapies and Nephrotoxicity This session by @rc_oncneph will focus on these newer therapies and an important question for nephrologists: what do we need to know about their renal effects? @onconeph @SheronLatcha @ShrutiGkidney

RT @NKF_NephPros: Explore Genetics in Kidney Care The Genetics in Kidney Health Summit Recordings Showcase brings together established approaches, emerging research, and patient stories. Watch on demand:

RT @onconephsociety: Update on Paraproteinemia and Kidney Pathologies: Monoclonal vs. Monotypic This session by Lihong Bu will look at monoclonal vs. monotypic patterns and the renal pathologies we need to recognise. @onconeph @SheronLatcha @rc_oncneph @ShrutiGkidney

RT @onconephsociety: Here’s the ASN Onconephrology Program at #KidneyWeek 2026 in Denver. A full day covering new therapies, kidney complications of cancer treatment, transplant, pathology, immunotherapy, & case-based discussions. Hope to see many of you there! @onconeph @rc_oncneph @SheronLatcha

RT @aHUSAllianceAct: Keep growing your clinical knowledge after #aHUS24Sept. 📈Join the Society of Critical Care Medicine (@SCCM) this Friday for a webcast on accelerating diagnosis and improving outcomes for atypical HUS & #TMA. 🗓️25 Sept 2026⏰ 10:00 - 11:00 AM CT #aHUS #CriticalCare #MedEd

RT @aHUSAllianceAct: Keep growing your clinical knowledge after #aHUS24Sept. 📈Join the Society of Critical Care Medicine (@SCCM ) TODAY for a webcast on accelerating diagnosis and improving outcomes for atypical HUS & #TMA. 🗓️25 Sept 2026⏰ 10:00 - 11:00 AM CT #aHUS #CriticalCare #MedEd

Today, on #aHUSAwarenessDay, we recognize the patients and families living with a rare and often unpredictable disease, and the community working alongside them!! Every story adds to what we know. Every question still unanswered gives us a reason to keep going.

RT @aHUS24Sept: 🔬 Diagnosing #aHUS remains a clinical challenge. Clinicians & researchers: Help others navigate complex aHUS diagnosis & care by sharing your work/insights with colleagues w/#aHUS24Sept. An expert review from @anuja_java on this complex #raredisease: